Trial
NCT02720484
Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Northwestern University
Collaborators
National Cancer Institute (NCI)
Condition
Metastatic Carcinoma in the Adrenal Cortex
Intervention
Laboratory Biomarker Analysis
Why stopped
Study did not meet first stage requirements of interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-01